In the last few decades, the epithelial cell adhesion molecule (EpCAM) has received
increased attention as the main membrane marker used in many enrichment technologies to …

Epithelial cell adhesion molecule (EpCAM) is a cell surface protein that was discovered as a
tumour marker of epithelial origins nearly four decades ago. EpCAM is expressed at basal …

Hypopharyngeal squamous cell carcinoma (HSCC) accounts 95% of hypopharyngeal
cancer, which is characterized by high early metastasis rate and poor prognosis. It is …

Abstract Background Syndecan-1 (SDC-1) is a crucial membrane proteoglycan, which is
confirmed to participate in several tumor cell biological processes. However, the biological …

As an intelligent disease, tumors apply several pathways to evade the immune system. It can
use alternative routes to bypass intracellular signaling pathways, such as nuclear factor-κB …

Background Prostate cancer is a common malignancy and the second leading cause of
cancer death in men. Elevated expression of the transcription factor FoxM1 and c-Myc has …

Over the past 50 years, breast cancer immunotherapy has emerged as an active field of
research, generating novel, targeted treatments for the disease. Immunotherapies carry …

Globally over 2 million women are diagnosed with breast cancer each year despite major
advances in detection and treatment of the disease. Breast cancer is comprised of several …

EpCAM, known as an epithelial cell adhesion molecule, plays an essential role in cell
adhesion, migration, metastasis and cell signalling. Rather than acting as an apoptosis …

We investigated differential gene expression in Tilapia infected with the Tilapia Lake virus
(TiLV). We used high-throughput sequencing to identify mRNAs and miRNAs involved in …